http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140066991-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18910de2653c0a59160eb05041e6ae7c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2012-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4dd84a0c95f8083a85b5f6e6f8257c3 |
| publicationDate | 2014-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20140066991-A |
| titleOfInvention | Sensitivity-enhanced cell-mediated immune response assay |
| abstract | This disclosure relates generally to the field of immuno-based diagnostic assays, including assays to measure cell-mediated immune reactivity. This disclosure teaches the diagnosis of exposure of a subject to an antigen based on sensitivity enhanced cell-mediated immunoreactivity. Contacting a lymphocyte from a subject with a first set comprising at least one peptide having a length of at least 7 to 14 amino acid residues and a second set comprising at least one peptide of 16 or more amino acid residues, Ascend. By incorporating the assays considered herein into a standard pathology state architecture, a diagnostic reporting system can be provided and on-site clinical treatment can be facilitated. |
| priorityDate | 2011-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 352.